Insider trade

Argan, Inc. (AGX): Director sold ~$896K

William F. Leimkuhler, Director at Argan, Inc., sold ~$896K of Argan, Inc. shares.

~$896K
Approx. value · 4,051 sh @ $221.25
58K
Holds after · shares reported
Traded
Jun 27, 2025
Filed
Jun 30, 2025

What stands out in this filing

  • The sale was 6.5% of the shares this insider held before it; the filing reports 58,240 shares afterwards.
  • 4,051 shares at an average of $221.25 each, as reported on the form.
  • No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Apr 30, 2025InsiderCFO sold ~$238K of AGX shares in the open market
  2. Jun 9, 2025Insider · 3 peopleInsiders: 3 sales (~$2.0M)
  3. Jun 10, 2025InsiderDirector sold ~$8.32M of AGX shares in the open market
  4. Jun 11, 2025Insider · 3 peopleInsiders: 3 sales (~$8.7M)
  5. Jun 12, 2025InsiderDirector sold ~$3.31M of AGX shares in the open market
  6. Jun 26, 2025InsiderDirector sold ~$733K of AGX shares in the open market
  7. Jun 27, 2025 · this disclosureInsiderDirector sold ~$896K of AGX shares in the open market

What came next

  1. Jun 30, 2025InsiderDirector sold ~$1.69M of AGX shares in the open market
  2. Jul 29, 2025Insider · 2 peopleInsiders: 2 sales (~$980K)
  3. Jul 30, 2025InsiderDirector sold ~$469K of AGX shares in the open market
  4. Jul 31, 2025Insider · 2 peopleInsiders: 2 sales (~$1.6M)
  5. Sep 17, 2025InsiderDirector sold ~$625K of AGX shares in the open market
  6. Sep 18, 2025InsiderCEO sold ~$1.93M of AGX shares in the open market
  7. Sep 19, 2025Insider · 3 peopleInsiders: 3 sales (~$3.5M)
  8. Sep 22, 2025InsiderDirector sold ~$1.21M of AGX shares in the open market
  9. Sep 24, 2025InsiderCEO sold ~$1.33M of AGX shares in the open market
  10. Oct 8, 2025Insider · Their largest sale since 2015Director sold ~$4.08M of AGX shares in the open market
  11. Oct 9, 2025Insider · 1 personInsiders: 2 sales (~$1.4M)
  12. Oct 13, 2025InsiderCEO sold ~$2.92M of AGX shares in the open market
  13. Oct 15, 2025InsiderCEO sold ~$3.09M of AGX shares in the open market
  14. Oct 17, 2025InsiderDirector sold ~$584K of AGX shares in the open market
  15. Oct 20, 2025Insider · Their largest sale since 2016Director sold ~$1.91M of AGX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Argan, Inc.

For Argan, Inc., OQRO holds 3 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AGX page.

Other recent filings by William F. Leimkuhler, Director

The full history of William F. Leimkuhler, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Argan, Inc. (AGX) insider traded, and how much?

William F. Leimkuhler, Director at Argan, Inc., sold ~$896K of Argan, Inc. shares. 4,051 shares at $221.25.

When did it happen, and when was it made public?

Traded: Jun 27, 2025. Filed: Jun 30, 2025. That is 3 days between the two dates.

What stands out in this filing?

The sale was 6.5% of the shares this insider held before it; the filing reports 58,240 shares afterwards. 4,051 shares at an average of $221.25 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Argan, Inc. recently?

For Argan, Inc., OQRO holds 3 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days. They are listed on the AGX page.

Does this mean AGX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Argan, Inc.

Everything OQRO holds on this company is on its AGX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data